Zach Hiser, testicular cancer survivor and his wife

Urologic Cancer

The U-M Health Rogel Cancer Center brings together a multidisciplinary team working to improve the diagnosis and treatment of urologic cancers, such as bladder, kidney and prostate cancer.

Call for an appointment: 734-647-8902

The Rogel Cancer Center and Michigan Medicine's Urology Department assembled a multidisciplinary team of doctors and researchers working together to improve the diagnosis and treatment of urologic cancers, such as bladder, kidney and prostate cancer.

Our patients have access to treatment options that include robotic surgery, genetic sequencing for more advanced or high risk prostate cancer patients, active surveillance, the latest in radiation techniques and all phases of clinical trials. Our multidisciplinary tumor board meets once a week to discuss patients care plans to offer the most optimal treatment option.

Looking for a Doctor or Location?

Find a Doctor

Locations

Our Expertise Includes

Questions about cancer?

Contact our Cancer AnswerLine™ at 800-865-1125. You'll talk to a nurse with years of experience in cancer care.

Learn More

News & Stories

cup sample with orange top in front of toilet

Health Lab

Urine-based test detects aggressive prostate cancer

Researchers at have validated a previously developed urine test, which can potentially bypass invasive procedures for prostate cancer detection among men who are unlikely to benefit.

group of medical teammates huddled around the MRI machine

Health Lab

New prostate biopsy technique shows potential future of MRI

Michigan Medicine specialists are investigating new in-bore, MRI-guided prostate biopsy techniques, which can help patients not served by standard methods.

Cancer Aware

Pathology’s Role in Cancer Care

After a patient has a biopsy, the samples are sent to pathology to determine if it is cancerous or not as well as how aggressive it is. Many patients will see their results before hearing from the medical team in their patient portal – leaving them anxious or confused on what it all means. Pathologist, Dr. Cathyrn Lapedis, talks about the role of pathology in a patient’s care plan, as well as new ways to help patients when they get results before their physician is able go over to help them with anxiety and to be better informed about their potential diagnosis.

ribbons in colorful colors lined up next to eachother

Health Lab

5-year survival rate has increased for all cancers, according to American Cancer Society

The American Cancer Society reports that mortality rates have continued to decline since the 1990s. N. Lynn Henry, of Michigan Medicine, answers questions about how factors such as healthy lifestyle choices, early screening and clinical trials have improved cancer survival rates.

microscope drawing in navy and yellow with off white background

Health Lab

Model predicts long term mortality risk from prostate cancer

Existing risk calculators for prostate cancer have less accurate estimates or predict risk through tests based on biopsy, which requires tissue samples and extra processing times. U-M researchers have developed a new model that can help doctors and patients understand their PSA results and what it means for patient life expectancy.

Cancer Aware

Understanding Prostate Biopsy

Those with an elevated prostate-specific antigen test are referred for a biopsy of their prostate to help diagnose prostate cancer or other prostate concerns. This can bring anxiety and discomfort for the patient.